| Nov 14, 2013
| 4:38 PM
Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
| Sep 26, 2011
| 4:05 AM
CHICAGO (Reuters) - Genetic differences could explain why some 40 percent of people with asthma do not respond to inhaled steroids used to achieve long-term asthma control.
U.S. researchers have found that asthma patients who inherited two copies of a...
| Sep 27, 2011
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
Doctors in the...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
| Apr 4, 2011
| 6:03 AM
There's no telling how many people have been affected by a massive electronic security breach. Hackers broke into the customer data of email marketing company Epsilon and accessed some of customers' personal information, including their emails.
| Jan 8, 2011
Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday.
The drugs, known as "atypical...
| Oct 27, 2012
| 1:45 PM
Dean's Guests Include:
Medical Expert: Dr. Kathy Albain - Medical Oncologist (Specialty: Breast Cancer) - Loyola University Medical Center - Cardinal Bernardin Cancer Center
Link to Dr. Albain's biographyWebsite
Medical Expert: Dr. Claudia Perez -...
| Nov 18, 2012
When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."
Two decades later, the senior vice president for...
| Jul 16, 2012
| 4:00 PM
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...
| Mar 15, 2012
| 6:11 PM
Maryland succeeded in raising $84 million to invest in promising technology companies across the state via a novel online auction of tax credits, officials announced Thursday.
The InvestMaryland plan, a cornerstone of Gov. Martin O'Malley's legislative...
| Sep 3, 2012
| 4:02 AM
CHICAGO (Reuters) - Adults who took inhaled steroids as children to control their asthma may be shorter than they otherwise would have been, but only by a little, U.S. researchers said on Monday.
Results of a long-term asthma study found that children...